104 related articles for article (PubMed ID: 32727978)
1. An update on cardio-oncology.
Herrmann J; Lerman A
Trends Cardiovasc Med; 2014 Oct; 24(7):285-95. PubMed ID: 25153017
[TBL] [Abstract][Full Text] [Related]
2. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
[TBL] [Abstract][Full Text] [Related]
3. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
Fatunde OA; Brown SA
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Strategies for Early Recognition of Cancer Therapeutics-Related Cardiac Dysfunction.
Manrique CR; Park M; Tiwari N; Plana JC; Garcia MJ
Clin Med Insights Cardiol; 2017; 11():1179546817697983. PubMed ID: 28469492
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment.
Mauro C; Capone V; Cocchia R; Cademartiri F; Riccardi F; Arcopinto M; Alshahid M; Anwar K; Carafa M; Carbone A; Castaldo R; Chianese S; Crisci G; D'Assante R; De Luca M; Franzese M; Galzerano D; Maffei V; Marra AM; Valente V; Giardino F; Mazza A; Ranieri B; D'Agostino A; Rega S; Romano L; Scagliarini S; Sepe C; Vriz O; Izzo R; Cittadini A; Bossone E; Salzano A
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983126
[TBL] [Abstract][Full Text] [Related]
6. Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology.
Rassaf T; Totzeck M; Backs J; Bokemeyer C; Hallek M; Hilfiker-Kleiner D; Hochhaus A; Lüftner D; Müller OJ; Neudorf U; Pfister R; von Haehling S; Lehmann LH; Bauersachs J;
Clin Res Cardiol; 2020 Oct; 109(10):1197-1222. PubMed ID: 32405737
[TBL] [Abstract][Full Text] [Related]
7. Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular Toxicity.
Pinheiro EA; Magdy T; Burridge PW
J Cardiovasc Transl Res; 2020 Jun; 13(3):377-389. PubMed ID: 32078739
[TBL] [Abstract][Full Text] [Related]
8. Genetic predisposition in chemotherapy-induced cardiomyopathy in a 65-year-old female with metastatic breast cancer.
Lee SY; Kim HS; Jung MH; Chang S; Kim M; Youn JC; Chung WB; Jung HO
ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38616291
[TBL] [Abstract][Full Text] [Related]
9. New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review.
Alexandraki A; Papageorgiou E; Zacharia M; Keramida K; Papakonstantinou A; Cipolla CM; Tsekoura D; Naka K; Mazzocco K; Mauri D; Tsiknakis M; Manikis GC; Marias K; Marcou Y; Kakouri E; Konstantinou I; Daniel M; Galazi M; Kampouroglou E; Ribnikar D; Brown C; Karanasiou G; Antoniades A; Fotiadis D; Filippatos G; Constantinidou A
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444400
[TBL] [Abstract][Full Text] [Related]
10. Cancer treatment-related cardiac dysfunction.
Brady B; Murphy R
BMJ Support Palliat Care; 2022 Jul; ():. PubMed ID: 35882516
[TBL] [Abstract][Full Text] [Related]
11. Cardio-Oncology rehabilitation- challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors.
Sase K; Kida K; Furukawa Y
J Cardiol; 2020 Dec; 76(6):559-567. PubMed ID: 32736905
[TBL] [Abstract][Full Text] [Related]
12. Ventricular Sigmoid Septum as a Risk Factor for Anthracycline-Induced Cancer Therapeutics-Related Cardiac Dysfunction in Patients With Malignant Lymphoma.
Nakayama T; Oshima Y; Shintani Y; Yamamoto J; Yokoi M; Ito T; Wakami K; Kitada S; Goto T; Hashimoto H; Kusumoto S; Sugiura T; Iida S; Seo Y
Circ Rep; 2022 Apr; 4(4):173-182. PubMed ID: 35434414
[No Abstract] [Full Text] [Related]
13. Harmonization of Cardiovascular and Oncology and the Blossoming of Cardio-Oncology in Japan.
Komuro I; Ishioka C
JACC CardioOncol; 2020 Dec; 2(5):819-821. PubMed ID: 34396301
[No Abstract] [Full Text] [Related]
14. Cardio-Oncology in Japan: The Rapidly Rising Sun.
Oka T; Akazawa H; Sase K; Hatake K; Komuro I
JACC CardioOncol; 2020 Dec; 2(5):815-818. PubMed ID: 34396300
[No Abstract] [Full Text] [Related]
15. Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events.
Kadowaki H; Akazawa H; Ishida J; Komuro I
JMA J; 2021 Apr; 4(2):91-98. PubMed ID: 33997442
[TBL] [Abstract][Full Text] [Related]
16. Cancer Therapeutics-Related Cardiac Dysfunction - Insights From Bench and Bedside of Onco-Cardiology.
Kadowaki H; Akazawa H; Ishida J; Komuro I
Circ J; 2020 Aug; 84(9):1446-1453. PubMed ID: 32727978
[TBL] [Abstract][Full Text] [Related]
17. [Cardiotoxicity of Cancer Chemotherapy - Mechanisms and Therapeutic Approach].
Akazawa H
Gan To Kagaku Ryoho; 2017 Dec; 44(13):2058-2063. PubMed ID: 29361617
[TBL] [Abstract][Full Text] [Related]
18. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
Lenneman CG; Sawyer DB
Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
[TBL] [Abstract][Full Text] [Related]
19. [Onco-Cardiology - From the Standpoint of Cardiology].
Shioyama W
Gan To Kagaku Ryoho; 2017 Dec; 44(13):2052-2057. PubMed ID: 29361616
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
